@article{KingslakeDiasDawsonetal.2017, author = {Kingslake, Jonathan and Dias, Rebecca and Dawson, Gerard R. and Simon, Judit and Goodwin, Guy M. and Harmer, Catherine J. and Morriss, Richard and Brown, Susan and Guo, Boliang and Dourish, Colin T. and Ruh{\´e}, Henricus G. and Lever, Anne G. and Veltman, Dick J. and van Schaik, Anneke and Deckert, J{\"u}rgen and Reif, Andreas and St{\"a}blein, Michael and Menke, Andreas and Gorwood, Philip and Voegeli, G{\´e}raldine and Perez, Victor and Browning, Michael}, title = {The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trial}, series = {Trials}, volume = {18}, journal = {Trials}, doi = {10.1186/s13063-017-2247-2}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-173012}, year = {2017}, abstract = {Background Antidepressant medication is commonly used to treat depression. However, many patients do not respond to the first medication prescribed and improvements in symptoms are generally only detectable by clinicians 4-6 weeks after the medication has been initiated. As a result, there is often a long delay between the decision to initiate an antidepressant medication and the identification of an effective treatment regimen. Previous work has demonstrated that antidepressant medications alter subtle measures of affective cognition in depressed patients, such as the appraisal of facial expression. Furthermore, these cognitive effects of antidepressants are apparent early in the course of treatment and can also predict later clinical response. This trial will assess whether an electronic test of affective cognition and symptoms (the Predicting Response to Depression Treatment Test; PReDicT Test) can be used to guide antidepressant treatment in depressed patients and, therefore, hasten treatment response compared to a control group of patients treated as usual. Methods/design The study is a randomised, two-arm, multi-centre, open-label, clinical investigation of a medical device, the PReDicT Test. It will be conducted in five European countries (UK, France, Spain, Germany and the Netherlands) in depressed patients who are commencing antidepressant medication. Patients will be randomised to treatment guided by the PReDicT Test (PReDicT arm) or to Treatment as Usual (TaU arm). Patients in the TaU arm will be treated as per current standard guidelines in their particular country. Patients in the PReDicT arm will complete the PReDicT Test after 1 (and if necessary, 2) weeks of treatment. If the test indicates non-response to the treatment, physicians will be advised to immediately alter the patient's antidepressant therapy by dose escalation or switching to another compound. The primary outcome of the study is the proportion of patients showing a clinical response (defined as 50\% or greater decrease in baseline scores of depressionmeasured using the Quick Inventory of Depressive Symptoms - Self-Rated questionnaire) at week 8. Health economic and acceptability data will also be collected and analysed. Discussion This trial will test the clinical efficacy, cost-effectiveness and acceptability of using the novel PReDicT Test to guide antidepressant treatment selection in depressed patients. Trial registration ClinicalTrials.gov, ID: NCT02790970. Registered on 30 March 2016.}, language = {en} } @article{DufnerKesslerJustetal.2022, author = {Dufner, Vera and Kessler, Almuth Friederike and Just, Larissa and Hau, Peter and Bumes, Elisabeth and Pels, Hendrik Johannes and Grauer, Oliver Martin and Wiese, Bettina and L{\"o}hr, Mario and Jordan, Karin and Strik, Herwig}, title = {The emesis trial: depressive glioma patients are more affected by chemotherapy-induced nausea and vomiting}, series = {Frontiers in Neurology}, volume = {13}, journal = {Frontiers in Neurology}, issn = {1664-2295}, doi = {10.3389/fneur.2022.773265}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-262859}, year = {2022}, abstract = {Purpose Glioma patients face a limited life expectancy and at the same time, they suffer from afflicting symptoms and undesired effects of tumor treatment. Apart from bone marrow suppression, standard chemotherapy with temozolomide causes nausea, emesis and loss of appetite. In this pilot study, we investigated how chemotherapy-induced nausea and vomiting (CINV) affects the patients' levels of depression and their quality of life. Methods In this prospective observational multicentre study (n = 87), nausea, emesis and loss of appetite were evaluated with an expanded MASCC questionnaire, covering 10 days during the first and the second cycle of chemotherapy. Quality of life was assessed with the EORTC QLQ-C30 and BN 20 questionnaire and levels of depression with the PHQ-9 inventory before and after the first and second cycle of chemotherapy. Results CINV affected a minor part of patients. If present, it reached its maximum at day 3 and decreased to baseline level not before day 8. Levels of depression increased significantly after the first cycle of chemotherapy, but decreased during the further course of treatment. Patients with higher levels of depression were more severely affected by CINV and showed a lower quality of life through all time-points. Conclusion We conclude that symptoms of depression should be perceived in advance and treated in order to avoid more severe side effects of tumor treatment. Additionally, in affected patients, delayed nausea was most prominent, pointing toward an activation of the NK1 receptor. We conclude that long acting antiemetics are necessary totreat temozolomide-induced nausea.}, language = {en} } @article{FischerKnopDanhofetal.2022, author = {Fischer, Julia and Knop, Stefan and Danhof, Sophia and Einsele, Hermann and Keller, Daniela and L{\"o}ffler, Claudia}, title = {The influence of baseline characteristics, treatment and depression on health-related quality of life in patients with multiple myeloma: a prospective observational study}, series = {BMC Cancer}, volume = {22}, journal = {BMC Cancer}, doi = {10.1186/s12885-022-10101-9}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-300435}, year = {2022}, abstract = {Background Multiple myeloma (MM) is the third most common hematologic malignancy with increasing importance due to improving treatment strategies and long-term outcomes in an aging population. This study aims to analyse influencing factors on health-related quality of life (HRQoL), such as treatment strategies, participation in a clinical trial and patient characteristics like anxiety, depression, gender, and age. A better understanding of the individual factors in context with HRQoL could provide a helpful instrument for clinical decisions. Methods In this prospective observational study, the HRQoL of MM patients with different therapies (first-line and relapse) was quantified by standardized questionnaires (EORTC QLQ-C30 and -MY20) in the context of sociodemographic data, individual anxiety and depressiveness (PHQ-4), and a selected number of clinical parameters and symptoms at defined time-points before, during, and after therapy. Results In total, 70 patients were included in the study. The median age of the study cohort was 62 years. 44\% were female and 56\% were male patients. More than half of the patients were fully active with an ECOG 0. Global health status was significantly higher in patients with first-line treatment and even increased after start of therapy, while the pain level decreased. In contrast, patients with relapsed MM reported a decreasing global health status and increasing pain. Additionally, there was a higher global health status in less anxious/depressive patients. HRQoL decreased significantly after start of chemotherapy in the parameters body image, side effects of treatment, and cognitive functioning. Tandem stem-cell transplantation was not found to be a risk factor for higher impairment of HRQoL. Participation in a clinical study led to an improvement of most aspects of HRQoL. Among others, increased anxiety and depression, female gender, older age, impaired performance status, and recurrent disease can be early indicators for a reduced HRQoL. Conclusion This study showed the importance of regular longitudinal assessments of patient reported outcomes (PROs) in routine clinical care. For the first time, to our knowledge, we were able to demonstrate a potential impact between participation in clinical trials and HRQoL. However, due to frequently restrictive inclusion criteria for clinical trials, these MM patients might not be directly comparable with patients treated within standard therapy concepts. Further studies are needed to clarify the relevance of this preliminary data in order to develop an individualized, patient-centred, therapy concept.}, language = {en} } @phdthesis{Kaese2011, author = {K{\"a}se, Mirjam}, title = {Transkranielle Theta Burst Behandlung depressiver Patienten: Untersuchung der Wirkung auf evozierte Potentiale in einem Oddball Paradigma}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-69314}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2011}, abstract = {Ziel der vorliegenden Arbeit war es die Wirksamkeit einer Behandlung mit Transkranieller Magnetstimulation bei depressiven Patienten zu untersuchen. Der Behandlungserfolg wurde mit depressionsspezfischen Frageb{\"o}gen, der Testleistung in einer kognitiven Aufgabe und ereigniskorrelierten Potentialen im EEG objektiviert. Es konnte nicht abschließend gekl{\"a}rt werden, ob die Theta-Burst-Stimulation in der Therapie depressiver Patienten geeignet ist. Es fanden sich allerdings Hinweise darauf, dass die pr{\"a}frontal applizierte Behandlung Ver{\"a}nderungen in den frontal generierten ereigniskorrelierten Potentialen bewirkte.}, subject = {Chronische Depression}, language = {de} } @article{KittelSchneiderFeliceBuhagiaretal.2022, author = {Kittel-Schneider, Sarah and Felice, Ethel and Buhagiar, Rachel and Lambregtse-van den Berg, Mijke and Wilson, Claire A. and Banjac Baljak, Visnja and Vujovic, Katarina Savic and Medic, Branislava and Opankovic, Ana and Fonseca, Ana and Lupattelli, Angela}, title = {Treatment of peripartum depression with antidepressants and other psychotropic medications: a synthesis of clinical practice guidelines in Europe}, series = {International Journal of Environmental Research and Public Health}, volume = {19}, journal = {International Journal of Environmental Research and Public Health}, number = {4}, issn = {1660-4601}, doi = {10.3390/ijerph19041973}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-262130}, year = {2022}, abstract = {This study examined (1) the availability and content of national CPGs for treatment of peripartum depression, including comorbid anxiety, with antidepressants and other psychotropics across Europe and (2) antidepressant and other psychotropic utilization data as an indicator of prescribers' compliance to the guidelines. We conducted a search using Medline and the Guidelines International Network database, combined with direct e-mail contact with national Riseup-PPD COST ACTION members and researchers within psychiatry. Of the 48 European countries examined, we screened 41 records and included 14 of them for full-text evaluation. After exclusion of ineligible and duplicate records, we included 12 CPGs. Multiple CPGs recommend antidepressant initiation or continuation based on maternal disease severity, non-response to first-line non-pharmacological interventions, and after risk-benefit assessment. Advice on treatment of comorbid anxiety is largely missing or unspecific. Antidepressant dispensing data suggest general prescribers' compliance with the preferred substances of the CPG, although country-specific differences were noted. To conclude, there is an urgent need for harmonized, up-to-date CPGs for pharmacological management of peripartum depression and comorbid anxiety in Europe. The recommendations need to be informed by the latest available evidence so that healthcare providers and women can make informed, evidence-based decisions about treatment choices.}, language = {en} } @phdthesis{Spieler2011, author = {Spieler, Christof}, title = {Ver{\"a}nderungen von biographischen Beurteilungen und Pers{\"o}nlichkeitsmerkmalen depressiver Patienten im Verlauf kognitiver Therapie}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-66592}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2011}, abstract = {Die als Eingruppen-Pr{\"a}-Post-Studie konzipierte Arbeit umfasste ein Probandengut von 46 Patienten mit der Diagnose einer Major Depression nach DSM-IV, die sich im Zeitraum von 1999 bis 2005 in ambulanter psychiatrischer Therapie befanden und nach Prinzipien und Methoden der kognitiven Verhaltenstherapie behandelt wurden. Mit dem Fragebogen f{\"u}r Psychovulnerabilit{\"a}t und Psychoprotektion (FPVP) wurden dabei biographische Merkmale sowie Pers{\"o}nlichkeitscharakteristika der Probanden erfasst. Zur quantitativen Beschreibung des momentanen Befindens dienten ferner die Eigenschaftsw{\"o}rterliste (EWL) sowie die Befindlichkeitsskala (Bf-S). Jeweils am Anfang sowie nach Abschluss der kognitiven Psychotherapie f{\"u}llten die Patienten die entsprechenden Frageb{\"o}gen aus. Eine {\"U}berpr{\"u}fung der so ermittelten Ergebnisse auf statistisch signifikante Ver{\"a}nderungen nach Abschluss der Therapie erfolgte mittels des Wilcoxon-Vorzeichen-Rangsummen-Testes. Außerdem wurden Spearman-Rangkorrelationskoeffizienten zwischen den pr{\"a}therapeutischen Werten der biographischen beziehungsweise pers{\"o}nlichkeitsbezogenen Variablen und den Ver{\"a}nderungen der allgemeinen Stimmungslage im Verlauf der Therapie errechnet. So sollte der Fragestellung nachgegangen werden, ob sich bestimmte Wesensmerkmale respektive biographische Einsch{\"a}tzungen der Probanden als Pr{\"a}diktoren f{\"u}r die Ver{\"a}nderungen des allgemeinen Befindens im Laufe einer psychotherapeutischen Depressionsbehandlung erweisen. Die Studie konnte einerseits aufzeigen, dass die psychovulnerablen FPVP-Pers{\"o}nlichkeitsvariablen „Neurotizismus" (NE) sowie „Desorganisation" (DO) und „Arbeitsbezogenheit" (AB) einer kognitiven Umstrukturierung zug{\"a}nglich waren. Gleiches galt f{\"u}r die psychoprotektive Pers{\"o}nlichkeitsvariable „Zielgerichtetheit" (ZG). Weiterhin konnte dargelegt werden, dass die biographischen Skalen „Kindliches Kontaktverhalten" (KI) sowie „Schulisches Engagement" (SCH), der Tatsache entsprechend, dass sie auf Erlebnissen und Erfahrungen basieren, die bereits in einer gewissen Weise stattgefunden haben, einer kognitiven Ver{\"a}nderung nicht unmittelbar zug{\"a}nglich waren. Andererseits zeigte sich, dass es im Verlauf der kognitiven Psychotherapie zu einer Verbesserung der gegenw{\"a}rtigen Stimmungslage und psychischen Befindlichkeit innerhalb des Patientenkollektivs kam. Dieses Ergebnis steht im Einklang mit zahlreichen fr{\"u}heren Studien, welche die hohe Effektivit{\"a}t der kognitiven Verhaltenstherapie bei der psychotherapeutischen Depressionsbehandlung hinreichend belegen. Außerdem wurde dargelegt, dass die Pr{\"a}-Werte der klinischen Skalen „Desorganisation" (DO) und „Neurotizismus" (NE) die Ver{\"a}nderungen der allgemeinen Stimmungslage im Laufe der kognitiven Therapie korrelativ beeinflussten. Je h{\"o}her n{\"a}mlich die pr{\"a}therapeutischen Scores der genannten Variablen ausfielen, umso ausgepr{\"a}gter verbesserte sich das psychische Befinden der Probanden verglichen mit den pr{\"a}therapeutischen Ausgangswerten. Schließlich imponierte der Befund, dass sich die psychische Befindlichkeit der Testpersonen im Laufe der Behandlung umso positiver ver{\"a}nderte, je h{\"o}her deren Introversions- beziehungsweise je geringer deren Extraversions-Werte zu Beginn der Therapie waren. Introvertierte Patienten scheinen demnach einen h{\"o}heren Nutzen von dem psychotherapeutischen Verfahren der kognitiven Umstrukturierung zu haben. Auf Grundlage dieser Ergebnisse sowie auf den Erkenntnissen fr{\"u}herer Arbeiten, welche bereits den Zusammenhang zwischen Pers{\"o}nlichkeit und aktuellem Befinden darlegen konnten, wurden Folgerungen f{\"u}r das klinisch-therapeutische Vorgehen gezogen: Durch bewusste F{\"o}rderung gewisser psychoprotektiver Faktoren beziehungsweise gezielte Abschw{\"a}chung und kognitive Umstrukturierung psychovulnerabler Pers{\"o}nlichkeitsvariablen l{\"a}sst sich die psychische Grundverfassung depressiver Patienten therapeutisch positiv beeinflussen. Biographische Merkmale k{\"o}nnen demgegen{\"u}ber nicht unmittelbar ver{\"a}ndert werden; jedoch ist es m{\"o}glich, dem Patienten eine ver{\"a}nderte Perspektive auf Aspekte seiner Lebensgeschichte zu vermitteln, was bis hin zu einer fiktiven Rekonstruktion der eigenen Biographie reichen kann. Der im Rahmen dieser Studie aufgezeigte Befund, dass ein erfolgreicher Verlauf der kognitiven Therapie mit hohen Introversions- respektive geringen Extraversions-Werten der Probanden korrelierte, wirft schließlich die Frage auf, ob die kognitive Verhaltenstherapie als ad{\"a}quates Therapieverfahren zur Behandlung depressiver Erkrankungen bei stark extravertierten Patienten verstanden werden kann. Da demgegen{\"u}ber gerade introvertierte, emotional labile Patienten von diesem psychotherapeutischen Verfahren zu profitieren scheinen, bietet sich die kognitive Therapie als geeignete Behandlungsmethode zur Therapie depressiver St{\"o}rungen bei solchen Patienten an.}, subject = {Depression}, language = {de} } @article{HeckmannPauli2022, author = {Heckmann, Manfred and Pauli, Martin}, title = {Visualizing presynaptic active zones and synaptic vesicles}, series = {Frontiers in Synaptic Neuroscience}, volume = {14}, journal = {Frontiers in Synaptic Neuroscience}, issn = {1663-3563}, doi = {10.3389/fnsyn.2022.901341}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-274687}, year = {2022}, abstract = {The presynaptic active zone (AZ) of chemical synapses is a highly dynamic compartment where synaptic vesicle fusion and neurotransmitter release take place. During evolution the AZ was optimized for speed, accuracy, and reliability of chemical synaptic transmission in combination with miniaturization and plasticity. Single-molecule localization microscopy (SMLM) offers nanometer spatial resolution as well as information about copy number, localization, and orientation of proteins of interest in AZs. This type of imaging allows quantifications of activity dependent AZ reorganizations, e.g., in the context of presynaptic homeostatic potentiation. In combination with high-pressure freezing and optogenetic or electrical stimulation AZs can be imaged with millisecond temporal resolution during synaptic activity. Therefore SMLM allows the determination of key parameters in the complex spatial environment of AZs, necessary for next generation simulations of chemical synapses with realistic protein arrangements.}, language = {en} } @phdthesis{Zech2021, author = {Zech, Linda}, title = {Vitamin-D-Status und depressive Symptome bei gerontopsychiatrischen Patienten}, doi = {10.25972/OPUS-25074}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-250745}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2021}, abstract = {In der vorliegenden Studie wurde der Zusammenhang des depressiven Syndroms mit dem Vitamin D-Spiegel an einer Stichprobe gerontopsychiatrischer Patienten (n = 140) der Neurogerontopsychiatrischen Tagesklinik W{\"u}rzburg untersucht. Die Depressivit{\"a}t der Patienten zu Beginn und im Verlauf der Behandlung wurde zum einen mittels der ICD-10-Klassifikation, zum anderen mittels des Scores auf der GDS- und Hamilton-Skala zu Beginn und Ende des Aufenthalts in der Tagesklinik sowie bei einer poststation{\"a}ren Kontrolle bestimmt. Der Vitamin D-Spiegel wurde bei Behandlungsbeginn bestimmt und im Falle eines Mangels 1000 IU Vitamin D am Tag oral substituiert. Hierbei zeigte sich kein Zusammenhang zwischen der Auspr{\"a}gung des depressiven Syndroms und dem Vitamin D-Spiegel zu Beginn der Behandlung. Dagegen stellte sich heraus, dass Patienten mit einem h{\"o}heren Spiegel eine deutlichere Verbesserung der depressiven Symptome auf der GDS im Verlauf der Behandlung erfuhren. Außerdem bestand eine signifikante negative Korrelation zwischen BMI und Vitamin D-Spiegel sowie eine Abh{\"a}ngigkeit der Spiegelh{\"o}he von der Jahreszeit. Vitamin D k{\"o}nnte nach den Ergebnissen dieser Studie m{\"o}glicherweise eine wirkungssteigernde und nebenwirkungsarme Komedikation in der antidepressiven Therapie von {\"a}lteren psychisch erkrankten Menschen darstellen. Es bedarf weiterer ausf{\"u}hrlicher Forschung {\"u}ber den neurophysiologischen Zusammenhang zwischen Vitamin D und der Schwere einer depressiven Erkrankung. Besonders hinsichtlich der Verwendung von Vitamin D als Komedikation gilt es, weitere intensive Forschung in Form von gut designten, randomisierten Fall-Kontroll-Studien und prospektiven Interventionsstudien zu betreiben, um die Therapie von depressiven Patienten im h{\"o}heren Lebensalter weiter zu verbessern.}, subject = {Altersdepression}, language = {de} } @article{BuchmannBaumannMengetal.2023, author = {Buchmann, J. and Baumann, N. and Meng, K. and Semrau, J. and Kuhl, J. and Pfeifer, K. and Vogel, H. and Faller, H.}, title = {Volitional Action Control and Depression in Chronic Pain: Does Action versus State Orientation Moderate the Relations of Pain-Related Cognitions to Depression?}, series = {Current Psychology}, volume = {42}, journal = {Current Psychology}, issn = {1046-1310}, doi = {10.1007/s12144-021-01914-1}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-308508}, pages = {7591-7608}, year = {2023}, abstract = {In this study, we examined the conditional indirect and direct relations of pain-related cognitions to depression. Subjective helplessness was included as presumably mediating the relations of catastrophizing and thought suppression to depression due to motivational deficits. In addition, moderating effects of dispositional action versus state orientation were analyzed, whereby state orientation indicates volitional deficits in coping with distress. The study was based on self-report data from 536 patients with chronic non-specific low back pain at the beginning of inpatient rehabilitation. Moderated mediation analyses were performed. The indirect catastrophizing- and thought suppression-depression relations were (partially) mediated by subjective helplessness; and moderated by failure-related action versus state orientation. Moreover, action versus state orientation moderated the direct relation of thought suppression to depression. Results suggest that catastrophizing, thought suppression, and subjective helplessness do not lead to depression unless associated with self-regulatory inability (i.e., state orientation). In contrast, action-oriented patients more effectively self-regulate pain-related emotions, disengage from rumination, and distract from pain and thus better avoid the debilitating effects of negative pain-related cognitions on depression. Future research and treatment may more strongly focus on the role of motivational and volitional deficits underlying learned helplessness and depression in chronic pain.}, language = {en} } @phdthesis{Scheiner2024, author = {Scheiner, Christin}, title = {Vulnerability in adolescence: prevalence, pandemic impact and prevention}, doi = {10.25972/OPUS-35164}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-351644}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2024}, abstract = {This compilation focuses on adolescent mental disorders and their prevention. It comprises three distinct studies, each contributing to a deeper understanding of this critical topic. This work addresses a critical gap in the understanding of, and approach to, adolescent mental health, and as a result reveals a critically important and urgently needed policy implication for action. The thematic structure of these studies begins with an examination of the epidemiology of child and adolescent mental disorders. Baseline data were collected from N = 877 adolescents with a mean age of 12.43 years (SD = 0.65). Mental health problems, such as depressive symptoms, non-suicidal self-injury, suicidal ideation, symptoms of eating disorders, and gender differences, are thoroughly examined. Results revealed a significant portion of our sample displaying mental health problems as early as the 6th and 7th grades, with girls generally being more affected than boys. The findings underscore the importance of early adolescence in the emergence of mental health problems and thereby emphasize the need for preventive measures. Moving beyond prevalence estimates, the compilation delves into the etiology of these disorders, exploring their potential correlation with a COVID-19 infection. Understanding the early signs and risk factors is crucial for timely support. While numerous studies have investigated potential risk and protective factors during the pandemic, our focus shifts to adolescents' coping when an infection with the virus was involved (N = 2,154, M = 12.31, SD = 0.67). We hypothesized that students infected or with close family members infected, would exhibit an increased psychopathology and a decreased functioning of protective factors such as self-efficacy or self-esteem. We found no connection between infection and the mental health status within our sample, but protective factors and mental well-being were positively associated. Thus, universal primary prevention appears to be the preferred approach for promoting mental health. Lastly, the compilation introduces LessStress, a noteworthy contribution to more evidence-based prevention programs. This universal approach is designed to reduce stress in schools, accompanied by a cluster-randomized trial to evaluate its effectiveness (estimated sample size N = 1,894). Existing studies have demonstrated the effectiveness of stress prevention, leading us to introduce a short and easy-to-implement prevention program. There is positive evidence for one-lesson interventions in schools for promoting well-being and health behaviors among adolescents. LessStress is designed based on a life skills approach that not only imparts psychoeducational content but also teaches skills relevant to everyday life and directly applicable. Throughout these studies, a common thread emerges: the pressing need to address mental disorders during childhood and adolescence. These formative years play a pivotal role in the development of mental health problems. These formative years play a crucial role in the development of mental health problems. They highlight the importance of epidemiological data collection and analysis based on the latest models to develop prevention interventions that are not only effective but also reach young people on a global level.}, subject = {Jugend}, language = {en} }